Skip to main content

Newsroom

Press Releases

31/07/26 - 12:50

Price sensitive
Revenue and EBITDA Supported by Strong Q2 Growth in the First Half of the Year. 2026 Guidance Confirmed.
Financial Data

19/06/26 - 15:45

Diasorin Announces FDA 510(K) Clearance and CLIA Waiver for the LIAISON NES Group A Streptococcus (GAS) Assay
Products Molecular

Press kit

Learn More

Video gallery

Learn More

Image gallery

Learn More